187 related articles for article (PubMed ID: 11071968)
1. Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis.
Zarif L; Covic A; Iyengar S; Sehgal AR; Sedor JR; Schelling JR
Nephrol Dial Transplant; 2000 Nov; 15(11):1801-7. PubMed ID: 11071968
[TBL] [Abstract][Full Text] [Related]
2. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
Covic AM; Schelling JR; Constantiner M; Iyengar SK; Sedor JR
Kidney Int; 2000 Oct; 58(4):1742-50. PubMed ID: 11012908
[TBL] [Abstract][Full Text] [Related]
3. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.
Obialo CI; Hewan-Lowe K
J Natl Med Assoc; 1998 Nov; 90(11):649-55. PubMed ID: 9828579
[TBL] [Abstract][Full Text] [Related]
4. A family-based strategy to identify genes for diabetic nephropathy.
Covic AM; Iyengar SK; Olson JM; Sehgal AR; Constantiner M; Jedrey C; Kara M; Sabbagh E; Sedor JR; Schelling JR
Am J Kidney Dis; 2001 Mar; 37(3):638-47. PubMed ID: 11228193
[TBL] [Abstract][Full Text] [Related]
5. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans.
Freedman BI; Yu H; Spray BJ; Rich SS; Rothschild CB; Bowden DW
Kidney Int; 1997 Mar; 51(3):819-25. PubMed ID: 9067916
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.
Liang S; Le W; Liang D; Chen H; Xu F; Chen H; Liu Z; Zeng C
BMC Nephrol; 2016 Apr; 17():42. PubMed ID: 27066888
[TBL] [Abstract][Full Text] [Related]
7. The familial risk of end-stage renal disease in African Americans.
Freedman BI; Spray BJ; Tuttle AB; Buckalew VM
Am J Kidney Dis; 1993 Apr; 21(4):387-93. PubMed ID: 8465818
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators.
Fogo A; Breyer JA; Smith MC; Cleveland WH; Agodoa L; Kirk KA; Glassock R
Kidney Int; 1997 Jan; 51(1):244-52. PubMed ID: 8995739
[TBL] [Abstract][Full Text] [Related]
9. The link between hypertension and nephrosclerosis.
Freedman BI; Iskandar SS; Appel RG
Am J Kidney Dis; 1995 Feb; 25(2):207-21. PubMed ID: 7847347
[TBL] [Abstract][Full Text] [Related]
10. [Hypertensive nephrosclerosis].
Krummel T; Bazin D; Faller AL; Hannedouche T
Presse Med; 2012 Feb; 41(2):116-24. PubMed ID: 21641755
[TBL] [Abstract][Full Text] [Related]
11. The MTHFR 677TT and 677CT/1298AC genotypes in Cypriot patients may be predisposing to hypertensive nephrosclerosis and chronic renal failure.
Koupepidou P; Deltas C; Christofides TC; Athanasiou Y; Zouvani I; Pierides A
Int Angiol; 2005 Sep; 24(3):287-94. PubMed ID: 16158041
[TBL] [Abstract][Full Text] [Related]
12. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of nitric oxide and endothelin in end-stage renal disease.
Freedman BI; Yu H; Anderson PJ; Roh BH; Rich SS; Bowden DW
Nephrol Dial Transplant; 2000 Nov; 15(11):1794-800. PubMed ID: 11071967
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients.
Hirakawa S; Lange EM; Colicigno CJ; Freedman BI; Rich SS; Bowden DW
Am J Kidney Dis; 2003 Jul; 42(1):133-42. PubMed ID: 12830465
[TBL] [Abstract][Full Text] [Related]
15. Clinical documentation of end-stage renal disease due to hypertension.
Schlessinger SD; Tankersley MR; Curtis JJ
Am J Kidney Dis; 1994 May; 23(5):655-60. PubMed ID: 8172207
[TBL] [Abstract][Full Text] [Related]
16. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus.
Freedman BI; Tuttle AB; Spray BJ
Am J Kidney Dis; 1995 May; 25(5):710-3. PubMed ID: 7747724
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.
Lewis J; Agodoa L; Cheek D; Greene T; Middleton J; O'Connor D; Ojo A; Phillips R; Sika M; Wright J;
Am J Kidney Dis; 2001 Oct; 38(4):744-53. PubMed ID: 11576877
[TBL] [Abstract][Full Text] [Related]
18. Genetic determinants of diabetic nephropathy: The family investigation of nephropathy and diabetes (FIND).
Family Investigation of Nephropathy and Diabetes Research Group
J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S202-4. PubMed ID: 12819329
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and pathological characteristics in patients with clinically presumed hypertensive nephrosclerosis].
Guo YS; Yuan WJ; Yu JP; Mei XB; Ye HY; Bian Q; Xu J
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):391-5. PubMed ID: 16776947
[TBL] [Abstract][Full Text] [Related]
20. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy.
Keene KL; Mychaleckyj JC; Smith SG; Leak TS; Perlegas PS; Langefeld CD; Freedman BI; Rich SS; Bowden DW; Sale MM
Diabetes; 2008 Apr; 57(4):1057-62. PubMed ID: 18184924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
